Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  UnitedHealth Group    UNH

UNITEDHEALTH GROUP (UNH)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales130 474157 107184 828200 298218 318235 890
EBITDA11 75212 71415 33517 33620 72922 902
Operating profit (EBIT)10 27411 67214 16215 35418 43820 562
Pre-Tax Profit (EBT)------
Net income5 6195 8137 2379 22710 10911 357
P/E ratio17,719,621,421,619,617,3
EPS ( $ )5,706,017,489,4110,311,8
Dividend per Share ( $ )1,411,882,382,462,733,46
Yield1,39%1,60%1,48%1,21%1,34%1,70%
Reference price ( $ )101.09117.64160.04203.25203.25203.25
Announcement Date01/21/2015
11:00am
01/19/2016
10:55am
01/17/2017
10:55am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt8 17019 18319 69515 3669 3993 454
Finance------
Operating income (EBITDA)11 75212 71415 33517 33620 72922 902
Leverage
(Debt/EBITDA)
0,70x1,51x1,28x0,89x0,45x0,15x
Capital Expenditure1 4471 5561 7051 8552 0022 097
Book Value Per Share (BVPS)33,7 $35,4 $40,3 $52,0 $58,7 $66,3 $
Cash Flow per Share8,16 $10,1 $10,1 $15,6 $14,1 $15,4 $
Announcement Date01/21/2015
11:00am
01/19/2016
10:55am
01/17/2017
10:55am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 196 514 M$ -
Entreprise Value (EV) 211 880 M$ 205 913 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 21,6x 19,6x
Capitalization / Revenue 0,98x 0,90x
EV / Revenue 1,06x 0,94x
EV / EBITDA 12,2x 9,93x
Yield (DPS / Price) 1,21% 1,34%
Price to book (Price / BVPS) 3,91x 3,46x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 7,67% 8,45%
operating Leverage (Delta EBIT / Delta Sales) 1,01x 2,23x
Net Margin (Net Profit / Revenue) 4,61% 4,63%
ROA (Net Profit / Asset) 7,27% 7,40%
ROE (Net Profit / Equities) 21,3% 20,1%
Rate of Dividend 26,2% 26,4%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   0,93% 0,92%
Cash Flow / Sales 7,53% 6,26%
Capital Intensity (Assets / Sales) 0,63x 0,63x
Financial Leverage (Net Debt / EBITDA) 0,89x 0,45x
EPS & Dividend